Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 3,634 | 3,499 | 8,365 | 13,217 | 19,303 |
Cost of Goods | 4,067 | 6,555 | 6,038 | 6,769 | 8,783 |
Gross Profit | -433 | -3,056 | 2,327 | 6,448 | 10,520 |
Operating Expenses | 7,932 | 8,851 | 8,843 | 11,875 | 10,428 |
Operating Income | -8,298 | -11,352 | -6,478 | -4,658 | 875 |
Interest Expense | 515 | 494 | 275 | 291 | 215 |
Other Income | -18 | 181 | -32 | 35 | -96 |
Pre-tax Income | -8,831 | -11,665 | -6,785 | -4,914 | 564 |
Income Tax | -2,566 | -2,914 | -1,644 | -1,474 | 14 |
Net Income Continuous | -6,265 | -8,751 | -5,141 | -3,440 | 550 |
Net Income | $-6,265 | $-8,751 | $-5,141 | $-3,440 | $550 |
EPS Basic Total Ops | -0.35 | -0.51 | -0.30 | -0.20 | 0.03 |
EPS Basic Continuous Ops | -0.35 | -0.50 | -0.30 | -0.20 | 0.03 |
EPS Diluted Total Ops | -0.35 | -0.51 | -0.30 | -0.20 | 0.03 |
EPS Diluted Continuous Ops | -0.35 | -0.50 | -0.30 | -0.20 | 0.03 |
EPS Diluted Before Non-Recurring Items | N/A | -0.51 | -0.30 | -0.20 | 0.03 |
EBITDA(a) | $-6,356 | $-9,379 | $-4,521 | $-3,155 | $2,272 |